# Li Zhang

Source: https://onco.cc/people/zhang-li-sysucc/  
OnCo record `zhang-li-sysucc` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Led the Chinese trials of PD-1 blockade in nasopharyngeal and lung cancer and the early studies of the EGFR×HER3 bispecific ADC iza-bren.

## Summary

Li Zhang is Professor of Medical Oncology and Director of the Department of Medical Oncology at Sun Yat-sen University Cancer Center in Guangzhou. He led the Chinese trials of PD-1 blockade with camrelizumab and toripalimab in nasopharyngeal carcinoma and lung cancer, and the early-phase studies of izalontamab brengitecan, the EGFR and HER3 bispecific antibody-drug conjugate from SystImmune and Sichuan Biokin, in non-small-cell lung cancer and nasopharyngeal carcinoma. His publications include the CAPTAIN-1st trial of camrelizumab added to gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma. His interests are lung cancer, nasopharyngeal carcinoma, immunotherapy and antibody-drug conjugates.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology; Director, Department of Medical Oncology, Sun Yat-sen University Cancer Center
- Specialisms: Lung cancer; Nasopharyngeal carcinoma; Immunotherapy; Antibody-drug conjugates

## Sources

- Sun Yat-sen University Cancer Center: https://www.sysucc.org.cn
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20L%5BAuthor%5D%20Sun%20Yat-sen%20lung%20cancer%20camrelizumab

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- drugs: [Camrelizumab](https://onco.cc/drugs/camrelizumab/), [Izalontamab brengitecan](https://onco.cc/drugs/izalontamab-brengitecan/), [Toripalimab](https://onco.cc/drugs/toripalimab/)
- companies: [SystImmune / Sichuan Biokin](https://onco.cc/companies/systimmune/)
- institutions: [Sun Yat-sen University Cancer Center](https://onco.cc/institutions/sysucc/)
- trials: [HARMONi-A](https://onco.cc/trials/harmoni-a/)

---
JSON: https://onco.cc/api/v1/entities/zhang-li-sysucc.json